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In vitro and in vivo responses to lipopolysaccharide (LPS) and various other bacterial immunostimulants were compared in C3H/He low-responder mice. The principal findings were as follows. (i) Their splenic lymphocytes were stimulated by various gram-negative mitogens such as an Escherichia coli peptidoglycan, a detoxified derivative of LPS, and even endotoxins extracted by trichloroacetic acid that are known to contain protein; spleen cells of these mice were also transformed by two other B-cell mitogens extracted from acid-fast organisms.
(ii) Their macrophages were refractory to LPS and weakly responsive to a mycobacterial preparation. (iii) LPS failed to elicit nonspecific resistance in these mice against Klebsiella pneumoniae infection. (iv) Endotoxin extracted by trichloroacetic acid and a mycobacterial preparation that could increase nonspecific resistance to infection in other strains did not protect C3H/ He mice against a challenge by K. pneumoniae, although both preparations could evoke nonspecific responses of B cells in this low-responder subline.
Bacterial endotoxins as isolated from gramnegative species by trichloroacetic acid or phenol-water procedures are potent immunogens and elicit a characteristic spectrum of immunologically significant responses in mice. They are nonspecific mitogens for spleen Bderived lymphocytes (2, 23) , adjuvants (12, 13) , and macrophage activators (1) and have been studied intensively for their dramatic effectiveness in enhancing natural resistance to infection (16, 25) . For example, the endotoxin-induced nonspecific mechanism delays bacterial proliferation in mice challenged with virulent Klebsiella and allows time for the establishment of the immune response (7, 20, 21) . A number of these host responses to endotoxin have been shown to be under genetic control; e.g., the HeJ strain of C3H mice manifests far fewer toxic reactions to lipopolysaccharides (LPS) than does the parent strain (27) , adjuvant property is no longer manifested, and the mitogenic response and polyclonal activation are either low or absent (24, 26, 29) .
We have recently demonstrated that LPS detoxified by phthalylation can still elicit blast transformation (6) . We have also reported that other nontoxic bacterial preparations, a Nocardia water-soluble extract (5) and Escherichia coli peptidoglycan (11) , evoke these in vitro effects on murine B lymphocytes. In contrast to LPS, these agents were unable to protect mice against infectious challenge. On the other hand, a mycobacterial preparation that did augment nonspecific tumor immunity (15) and activate macrophages (14) was also a murine Bcell mitogen and enhanced nonspecific resistance to Klebsiella (unpublished data). Further exploration of these compounds with distinctive biological attributes was made in LPS low-and high-responder mice in order to ascertain whether the induction of nonspecific immunity and B-lymphocyte response were under separate host control.
MATERIALS AND METHODS
Mice. Six-week-old C3H/He Orl. or C3Heb/Fe Orl. inbred female mice and (C57B1/6 x DBA/2) F, or BDFI Orl. mice were obtained from the Centre National de la Recherche Scientifique (Orl6ans, France). In some assays (C57B1/6 x AKR)F, hybrids of the same age and sex (Pasteur Institute) were also used.
Preparations. LPS was extracted from Salmonella enteritidis (Danysz strain) by phenol-water (30) . Detoxified sodium phthalate LPS of S. enteritidis (SPLPS) was prepared as previously described (6) , and bovine serum albumin treated by phthalic anhydride under the same conditions will be referred to as SPBSA. Endotoxin preparations (Boivin preparations (15) . Concanavalin A (Miles) was used as a Tcell mitogen control.
Blast transformation and macrophage activation. Culture and assay conditions for the study of stimulation by mitogens of mice spleen cells (5) and macrophage activation (14) were as described earlier. For the latter 2.5 x 104 P815 mastocytoma cells were added to monolayers of macrophages, and experimental results were expressed as growth inhibition percentage according to the formula: percentage of growth inhibition = (NR -AR)/NR x 100, in which NR represents normal radioactivity incorporated by mastocytoma cells cultured on control macrophage monolayers and AR represents radioactivity incorporated by mastocytoma cells cultured on activated macrophage monolayers.
Infection. Mice were infected intravenously with a virulent strain of Klebsiella pneumoniae of capsular type 2 (22) . Bacterial numbers in vivo were estimated as previously described (21) .
RESULTS
Mitogenic responses of LPS low responders to various gram-negative preparations. Spleen cells of C3H/He and C3HeB/Fe mice were incubated with various amounts of a phenol-water LPS extracted from S. enteritidis or TCA-Et extracted from S. enteritidis or from E. coli, or a peptidoglycan prepared from E. coli that can substitute for the mycobacterial cell walls in Freund complete adjuvant (19) and has also been shown to be a B-cell mitogen (11) .
The results in Fig. 1 represent a typical experiment and show that C3H/He mice were unresponsive to LPS whereas C3HeB/Fe were strongly stimulated. Moreover, the unrespon- Mitogenic responses of LPS low responders to a detoxified LPS derivative. It has been previously reported that after treatment by phthalic anhydride, LPS retains its adjuvant and mitogenic capacity but has lost its toxicity and its capacity to stimulate nonspecific resistance to bacterial infection (6).
In these experiments, spleen cells were incubated with various amounts of either SPLPS or LPS. SPBSA was used as a control (Fig. 2) . The lymphocytes of the low-responding strain were strongly stimulated by SPLPS, but they did not respond to high dosages of LPS. SPBSA had no discernible effect on the cells of both strains of mice.
Mitogenic responses of LPS low responders to B-cell mitogens extracted from acid-fast organisms. Spleen cells were incubated with various amounts of LPS, NWSM, or IPM. NWSM is a water-soluble extract of Nocardia known to be a nonspecific B-cell mitogen and a polyclonal B-cell activator of murine and rabbit (Fig. 3) . In all of these experiments, spleen cells of the low-responder strain were also well stimulated by a T-cell mitogen, concanavalin A. In all cases, mitogenic responses obtained with C3HeB/Fe spleen cells were comparable to those obtained with the cells of (C57B1/6 x AKR)F, hybrids also used as controls.
In vitro activation of macrophages by LPS or IPM. In these experiments, the tumor target cell was mastocytoma P815 raised on BDF, hybrids. In C3H strains, attesting to the absence of allogeneic activation. Therefore, peritoneal macrophages were harvested from C3H/He and from C3HeB/Fe or from syngeneic BDF, mice. Two kinds of experiments were performed. In the first, test macrophages pooled from groups of four mice of each C3H subline were incubated with 0.2, 2, or 20 ug of TCA-Et, phenol-water LPS, or IPM, preparations that had been shown to activate nonspecifically macrophages in vivo and in vitro (1, 14) . Macrophages harvested from allogeneic C3HeB/Fe mice activated by all three preparations show a marked inhibition of the growth of mastocytoma cells (Table 1 ). In contrast, macrophages of C3H/He mice were poorly activated by these three immunostimulants, the weakest response being observed in the case of LPS.
In other experiments, macrophages of low responders were compared with the cells of BDF, controls. For each dosage level, the cells of four mice were tested separately. As previ- (10, 27, 28 
